Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Proton Therapy
77%
Chemoradiotherapy
53%
Lung Cancer
53%
Radiation Therapy
36%
Neoplasm
30%
Intensity Modulated Radiation Therapy
24%
Radiation Pneumonia
19%
Overall Survival
17%
Durvalumab
16%
Volume CT
15%
Thorax Tumor
14%
Contouring
14%
Immunotherapy
14%
Small Cell Lung Cancer
14%
Non-Small Cell Lung Cancer
14%
Radiation Therapy
14%
Stereotactic Body Radiation Therapy
13%
Breathing
13%
Photon Therapy
13%
Volumetric Modulated Arc Therapy
12%
Conformal Radiotherapy
12%
Image Quality
12%
Positron Emission Tomography
12%
Primary Tumor
12%
Dose Calculation
12%
Acute Toxicity
10%
Lung Tumor
9%
Cone Beam Computed Tomography
8%
Odds Ratio
8%
Stereotactic Radiotherapy
8%
Radiation Therapy Planning
8%
Fluorodeoxyglucose F 18
8%
Radiation Oncology
7%
Dose-Volume Histogram
7%
Head and Neck Tumor
7%
Continuous Positive Airway Pressure
7%
Tumor Metabolism
7%
Bilevel Positive Airway Pressure
7%
Positron Emission Tomography
7%
Hypoxia
7%
Proteus
7%
Atrium (Heart)
7%
Breast Cancer
7%
Computer Assisted Tomography
7%
Ventricle (Heart)
7%
Pneumonia
7%
Cardiovascular System
7%
Ticilimumab
7%
Survival Prediction
7%
Keyphrases
Non-small Cell Lung Cancer Patients
36%
Lung Cancer
21%
4D Dose Accumulation
19%
Non-small Cell Lung Cancer (NSCLC)
17%
Chemoradiotherapy
16%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
15%
Normal Tissue Complication Probability
14%
Multivariable
14%
Intensity-modulated
14%
Acute Toxicity
14%
Normal Tissue Complication Probability Models
12%
4D Dose Reconstruction
12%
Esophageal Toxicity
12%
Radiotherapy
11%
Stereotactic Body Radiotherapy
10%
Deep Learning
8%
Stereotactic Radiotherapy
8%
Organs at Risk
8%
Cancer Audit
7%
Dutch
7%
Interface Test
7%
Immune Checkpoint Inhibitors
7%
Non-responders
7%
CD8+ T Cell Infiltration
7%
Normal Tissue Complications
7%
4DCT
7%
Radiation Dose
7%
Stage I-IIIA
7%
Assessment Method
7%
Intrafraction
7%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
7%
3-month Mortality
7%
Image Features
7%
Dose-surface Maps
7%
Reader Study
7%
Radiotherapy Boost
7%
Early Response Monitoring
7%
Netherlands
7%
Large-scale Motions
7%
Non-gated
7%
Proton Dose
7%
Cardiac Atria
7%
Survival Prediction
7%
Interfractional
7%
Continuous Beam
7%
Chemoradiation
7%
Small Cell Lung Cancer
7%
Respiratory Gating
7%
90-day Mortality
7%
Target Volume Delineation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
86%
Chemoradiation Therapy
58%
Lung Cancer
45%
Malignant Neoplasm
22%
Overall Survival
16%
Radiation Pneumonia
15%
Primary Tumor
14%
Acute Toxicity
10%
Cisplatin
10%
Neoplasm
9%
Immunotherapy
8%
Chemotherapy
8%
Cancer Staging
7%
Brain Metastasis
7%
Thorax Tumor
7%
Durvalumab
7%
Pneumonia
7%
Survival Prediction
7%
Tolerability
7%
Hodgkin Disease
7%
Chemotherapy Regimens
7%
Tremelimumab
7%
Heart Left Ventricle Failure
7%
Lung Toxicity
5%
Dose-Volume Histogram
5%